LABORATORY RESEARCH Exosomes from Bulk and Stem Cells from Human Prostate Cancer Have a Differential MicroRNA Content that Contributes Cooperatively over Local and Pre-Metastatic Niche Five prostate cancer primary cell cultures were established to originate bulk and cancer stem cells cultures. From them, exosomes were purified by precipitation for miRNAs extraction to perform a comparative profile of miRNAs by next generation sequencing in an Illumina platform. [Oncotarget] Full Article Fibroblasts Prolong Serum Prostate-Specific Antigen Decline after Androgen Deprivation Therapy in Prostate Cancer Scientists investigated the role of fibroblasts in serum prostate-specific antigen decline after androgen deprivation therapy. They performed in vitro experiments using androgen-sensitive, androgen receptor-positive prostate epithelial cell lines, commercially available prostate stromal cells, and primary cultures of prostate fibroblasts. [Lab Invest] Abstract Exosomal Particles Secreted by Prostate Cancer Cells Are Potent mRNA and Protein Vehicles for the Interference of Tumor and Tumor Environment Researchers characterized the mRNA and protein composition as well as cellular functions of prostate cancer cell-derived exosomes. Exosomes were prepared from prostate cancer cell culture supernatant by ultracentrifugation and subsequently characterized by dynamic light scattering and electron microscopy. [Prostate] Abstract Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating Investigators explored resistance mechanisms in the advanced type of prostate cancer cells and aimed to clarify the role of autophagy in these processes. [PLoS One] Full Article Malformin A1 Promotes Cell Death through Induction of Apoptosis, Necrosis and Autophagy in Prostate Cancer Cells Investigators reported the mode of mechanism underlying malformin A1-mediated cytotoxicity through induction of apoptosis, necrosis and autophagy in prostate cancer cells. [Cancer Chemother Pharmacol] Abstract Knockdown of GPR137,G Protein-Coupled Receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells To see whether GPR137 could serve as a potential therapeutic target for prostate cancer (CaP), GPR137 was knocked down to verify its biological function in CaP cells. The authors found that silencing of the GPR137 gene suppressed the proliferation and colony formation of CaP cell lines PC-3 and DU145. [Chem Biol Drug Des] Abstract Quercetin Inhibits Angiogenesis through Thrombospondin-1 Upregulation to Antagonize Human Prostate Cancer PC-3 Cell Growth In Vitro and In Vivo The authors explored the important role of thrombospondin-1 upregulation in reducing angiogenesis and anti-prostate cancer effect of quercetin both in vitro and in vivo for the first time. [Oncol Rep] Abstract CLINICAL RESEARCH Long-Term Outcome of a Phase II Trial Using Immunomodulatory In Situ Gene Therapy in Combination with Intensity-Modulated Radiotherapy with or without Hormonal Therapy in the Treatment of Prostate Cancer Investigators report the long-term outcome of a Phase II trial of immune-modulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy for the treatment of prostate cancer. [J Radiat Oncol] Abstract | Press Release |